Literature DB >> 22187645

Relationship between Vessel Diameter and Time to Maturation of Arteriovenous Fistula for Hemodialysis Access.

M Khavanin Zadeh1, F Gholipour, Z Naderpour, M Porfakharan.   

Abstract

Introduction. Native arteriovenous fistula (AVF) is the recommended vascular access for HD patients by the Dialysis Outcomes Quality Initiative (DOQI) guidelines. The aim of our study was to determine the correlation between diameter and maturation of vessels in radiocephalic AVF. Methods. A prospective cross-sectional study carried out during 2006-2007 on 96 hemodialysis patients from Hasheminejad Kidney Center with non probability selection, all of them with end to side native AVF. Results. In this population 62.5% had wrist (distal radial artery) AVF and 37.5% had antecubital (proximal radial artery) AVF. The mean diameter of artery was 2.57 mm (SD = 1.09) and the mean diameter of vein was 2.40 mm (SD = 0.79). The mean of maturation period was 38.60 days (SD = 42.13). There were no relationship between duration of maturation period and diabetes mellitus, sex, age, diameter of vein and artery (P > 0.05). Period of maturation showed some correlation with the diameter of vein (P = 0.04) in patients with distal radiocephalic fistulae. Conclusions. The maturation of fistula shows correlation with vein diameter, but no correlation was seen with diameter of the arteries. There is much discrepancy between times to maturation in various reports. The average time for fistula maturation was 38/6 days in our study.

Entities:  

Year:  2011        PMID: 22187645      PMCID: PMC3236464          DOI: 10.1155/2012/942950

Source DB:  PubMed          Journal:  Int J Nephrol


1. Introduction

Surgery for hemodialysis (HD) access is the most commonly performed vascular surgical operation in the United States, predominantly because of a steady increase in the prevalence of end-stage renal disease (ESRD) [1]. Native arteriovenous fistula (AVF) is the recommended vascular access for HD patients by the Dialysis Outcomes Quality Initiative (DOQI) guidelines. The current national kidney foundation (DOQI) guidelines endorse this practice and recommend that initial cannulation be delayed for at least four weeks following surgery [2]. A fistula is considered mature when it can achieve a 300 mL/min dialysis blood flow within 1–6 months of its creation. Failure to mature (primary failure) is defined as the inability to meet this goal. Native AVF composed only 17% of all initial permanent hemodialysis access procedures performed in Medicare patients from 1996 to 1997 [3]. In 2002, the dialysis outcomes and practice patterns study (DOPPS) [2], one of the largest prospective observational studies published on hemodialysis practices and outcome in 309 international dialysis facilities, reported that AVF accounted for 24% of all access procedures in the United States, compared with 80% in Europe [4]. Gold standard for AVF maturation is the clinical definition of a successful maturation. It is an AVF capable of being used for successive occasions of hemodialysis. Reported AVF maturation rate varies widely, from 30% to 90% [5-7], lower maturation rate may effectively reduce the functional patency of AVF to a level approaching that of prosthetic arteriovenous grafts [8]. Furthermore, AVF requires a longer period of maturation compared with prosthetic arteriovenous grafts. Protracted hemodialysis via percutaneous catheter may be required while awaiting fistula maturation, leading or increasing the risk for infection and compromise central vein patency [9]. The construction of a functional radiocephalic fistula can be challenging and high initial failure rates have been reported in many publications. Estimates of nonmaturation rated vary from just under 10% in brachiocephalic fistula to between 25% and 33% in radiocephalic fistula [10, 11]. The aim of our study was to determine the correlation between diameter and maturation of vessels in radiocephalic AVF.

2. Methods

A prospective cross-sectional study carried out during 2006-2007 on 96 hemodialysis patients from Hasheminejad Kidney Center with nonprobability selection, all of them with end to side native AVF. A checklist was used for collecting data about each patient's vein and artery diameter and time of fistula maturation according to their hospital records. Our criteria for AVF maturation was (1) easily palpable superficial vein, (2) vein relatively straight, (3) adequate diameter for easy cannulating needles (3-4 mm), (4) adequate length (≥10 cm, for adequate distance between the cannulating needles), and (5) uniform thrill to palpation and auscultation. We evaluated these criteria by nurses or nephrologists or surgeon. Data in this study included demographic characteristics such as age, gender, and past medical history, and data about their arterial diameter and time course of maturation were collected from medical records of the enrolled patients and analyzed using the SPSS for windows software, version 16 (SPSS Inc, Chicago, Il, USA). We used descriptive and analytic tests. P value less than 0.05 were considered statistically significant.

3. Results

From the patients of Hasheminejad Kidney Center during 2006-2007, a total of 96 with native AVF with mean age 54.70 (SD = 17.17) years; 58.3% male and 41.7% female enrolled in our study. In this population, 62.5% had wrist (distal radial artery) AVF, and 37.5% had antecubital (proximal radial artery) AVF. In our study, the mean diameter of artery was 2.57 mm (SD  =  1.09), and the mean diameter of vein was 2.40 mm (SD = 0.79). The mean of maturation period was 38.60 days (SD  =  42.13). In antecubital AVF, proximal radial artery diameter was 3.52 mm (SD = 1.08), the mean of vein diameter was 3 mm (SD = 0.69), and maturation period in this patients was 36.05 days (SD = 36.19). In patients with distal radiocephalic fistulae, the mean of artery diameter was 2 mm (SD = 0.6), and the mean of vein diameter was 2.05 mm (SD = 0.62); in this group, the mean of maturation period of AVF was 40.13 days (SD = 45.55). In our study for radiocephalic fistulae, there were no significant relationships between duration of maturation period and diabetes mellitus, sex, diameter of vein and artery, and age (P > 0.05). Meanwhile, in our study, period of maturation showed some correlation with the diameter of vein (P = 0.04) in patients with distal radiocephalic fistulae.

4. Discussion

The ideal hemodialysis access fistula should be durable, pose minimal risk for infection, and require few interventions to maintain ongoing functional patency. It is well documented that mature AVF demonstrate superior overall patency, lower revision rate, and cost savings, compared with prosthetic arteriovenous grafts [12]. Despite almost uniform agreement on the need to increase the AVF creation rate, prevalence in the United States has increased only modestly since publication of DOQI clinical practice guideline in 1997. Less than 30% of access sites in the United States are autogenous fistula [3]. Cannulation, 14 days after creation was associated with 2.1-fold increased risk of subsequent fistula failure compared to fistula cannulation more than14 days. No significant difference in AV fistula failure was seen for fistula cannulation in 15 to 28 days compared with 43 to 48 days [13]. The finding that use of vein with larger stream diameters was associated with greater success rate was consisting with the following studies. Three studies examined preoperative venous diameter and AVF adequacy for dialysis [6, 14, 15]. Wong et al. [15] found no difference in the average venous diameter at the wrist between failed and adequate AVF but reported that all AVF failed if the diameter was 1.6 mm or less. Mendes et al. [6] reported that 16% of AVF were adequate with a vein diameter of 2 mm or less, compared to 76% of those >2 mm. There is much discrepancy between time of maturation in various reports. For example, the median time to first fistula cannulation differed between countries, ranging from 28 days in Japan and Italy to 96 and 98 days in transplantation in UK and US, respectively [4]. According to our data, the maturation of fistula is correlated vein diameter with, but no correlation was seen with diameter of the arteries. There is much discrepancy between time of maturation in various reports. In NKF-K/DOQI guidelines, the average time for fistula maturation is reported to be 1 to 4 months, but in our study, it was 38.6 days. In some other surveys, there was a direct relation between maturation of fistula with both age and gender, but these were not seen in our study. In our data, no correlations were seen between diameter of arteries and age, gender, and diabetes. Future studies should be performed with more samples to evaluate these factors and also other factors which can decreases the period of fistula maturation.
  14 in total

1.  The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemodialysis patients?

Authors:  D A Goodkin; D L Mapes; P J Held
Journal:  Semin Dial       Date:  2001 May-Jun       Impact factor: 3.455

2.  The economic cost of ESRD, vascular access procedures, and Medicare spending for alternative modalities of treatment. USRDS. United States Renal Data System.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-08       Impact factor: 8.860

3.  Factors associated with early failure of arteriovenous fistulae for haemodialysis access.

Authors:  V Wong; R Ward; J Taylor; S Selvakumar; T V How; A Bakran
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-08       Impact factor: 7.069

4.  Vascular access use in Europe and the United States: results from the DOPPS.

Authors:  Ronald L Pisoni; Eric W Young; Dawn M Dykstra; Roger N Greenwood; Erwin Hecking; Brenda Gillespie; Robert A Wolfe; David A Goodkin; Philip J Held
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

5.  Superior maturation and patency of primary brachiocephalic and transposed basilic vein arteriovenous fistulae in patients with diabetes.

Authors:  A G Hakaim; M Nalbandian; T Scott
Journal:  J Vasc Surg       Date:  1998-01       Impact factor: 4.268

6.  Predictors of adequacy of arteriovenous fistulas in hemodialysis patients.

Authors:  P E Miller; A Tolwani; C P Luscy; M H Deierhoi; R Bailey; D T Redden; M Allon
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

7.  Longitudinal comparison of dialysis access methods: risk factors for failure.

Authors:  T C Hodges; M F Fillinger; R M Zwolak; D B Walsh; F Bech; J L Cronenwett
Journal:  J Vasc Surg       Date:  1997-12       Impact factor: 4.268

8.  Prospective evaluation of failure modes in autogenous radiocephalic wrist access for haemodialysis.

Authors:  Jan H M Tordoir; Patrick Rooyens; Ruben Dammers; Frank M van der Sande; Michiel de Haan; Tik Ien Yo
Journal:  Nephrol Dial Transplant       Date:  2003-02       Impact factor: 5.992

9.  Failure of dialysis access: revise or replace?

Authors:  T E Brothers; M Morgan; J G Robison; B M Elliott; P Baliga; J B Cofer; P R Rajagopolan; C T Fitts
Journal:  J Surg Res       Date:  1996-02-01       Impact factor: 2.192

10.  Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography.

Authors:  Robert R Mendes; Mark A Farber; William A Marston; Lesley C Dinwiddie; Blair A Keagy; Steven J Burnham
Journal:  J Vasc Surg       Date:  2002-09       Impact factor: 4.268

View more
  12 in total

Review 1.  New Insights into Dialysis Vascular Access: What Is the Optimal Vascular Access Type and Timing of Access Creation in CKD and Dialysis Patients?

Authors:  Karen Woo; Charmaine E Lok
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

2.  Less primary fistula failure in hypertensive patients.

Authors:  Mohammad Rezapour; Morteza Khavanin Zadeh; Mohammad Mehdi Sepehri; Mahmood Alborzi
Journal:  J Hum Hypertens       Date:  2018-03-27       Impact factor: 3.012

3.  Association between non-matured arterio-venus fistula and blood pressure in hemodialysis patients.

Authors:  Mohammad Rezapour; Morteza Khavaninzadeh
Journal:  Med J Islam Repub Iran       Date:  2014-12-08

4.  Very low protein diets supplemented with keto-analogues in ESRD predialysis patients and its effect on vascular stiffness and AVF Maturation.

Authors:  Cristiana David; Ileana Peride; Andrei Niculae; Alexandra Maria Constantin; Ionel Alexandru Checherita
Journal:  BMC Nephrol       Date:  2016-09-20       Impact factor: 2.388

Review 5.  Maturation of arteriovenous fistula: Analysis of key factors.

Authors:  Muhammad A Siddiqui; Suhel Ashraff; Thomas Carline
Journal:  Kidney Res Clin Pract       Date:  2017-12-31

6.  Rationale and design of the PHYSICALFAV trial: a randomized controlled trial to evaluate the effect of preoperative isometric exercise on vascular calibre and maturation of autologous arteriovenous fistulas.

Authors:  Ines Aragoncillo; Jose Manuel Ligero; Covadonga Hevia; Angel Luis Morales; Yésika Amézquita; Teresa Cervera; Almudena Vega; Soraya Abad; Nicolás Macías; Jose Luño
Journal:  Clin Kidney J       Date:  2018-06-22

7.  Correlation between preoperative vein and artery diameters and arteriovenous fistula outcome in patients with end-stage renal disease.

Authors:  Alexandru Oprea; Adrian Molnar; Dan Vlăduţiu; Traian Scridon; Cătălin Trifan; Diana Săcui; Vasile Săsărman; Petru Adrian Mircea
Journal:  Clujul Med       Date:  2018-10-30

8.  Predictive parameters of arteriovenous fistula functional maturation in a population of patients with end-stage renal disease.

Authors:  Khalid Bashar; Adeel Zafar; Sawsan Elsheikh; Donagh A Healy; Mary Clarke-Moloney; Liam Casserly; Paul E Burke; Eamon G Kavanagh; Stewart R Walsh
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

9.  The impact of vascular diameter ratio on hemodialysis maturation time: Evidence from data mining approaches and thermodynamics law.

Authors:  Mohammad Rezapour; Somayeh Taran; Mahmood Balin Parast; Morteza Khavanin Zadeh
Journal:  Med J Islam Repub Iran       Date:  2016-04-19

10.  Predictive parameters of arteriovenous fistula maturation in patients with end-stage renal disease.

Authors:  Muhammad A Siddiqui; Suhel Ashraff; Derek Santos; Robert Rush; Thomas Carline; Zahid Raza
Journal:  Kidney Res Clin Pract       Date:  2018-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.